GSK 241108 37.00C (GSK241108C37000) Stock Options, News & Quotes

US OptionsDetailed Quotes

GSK241108C37000

Watchlist

0.05
-0.31-86.11%

15min DelayTrading Nov 6 11:27 ET

0.05High0.04Low

Intraday

5D
Daily

News

Express News | GSK's AREXVY Vaccine Receives Expanded Approval In Canada For Adults Aged 50-59 At Increased Risk Of RSV, Offering Enhanced Protection Ahead Of Peak Season; Clinical Trials Ongoing For Adults 18-49
BenzingaNov 5 08:12 ET
Dermatology Treatment and Care Market Research 2024-2030 Featuring Novartis, Pfizer, Amgen, GlaxoSmithKline, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Merck & Co, Bayer, and Sanofi - ResearchAndMarkets.com
BusinesswireNov 4 07:43 ET
M&A Deals Roundup: AbbVie, Blackstone, Take-Two Interactive and More
Seeking AlphaNov 2 15:34 ET
GSK Cut to Neutral From Buy by Guggenheim
Dow JonesOct 31 14:45 ET · Ratings
GSK Analyst Ratings
BenzingaOct 31 14:30 ET · Ratings
GSK Downgraded at Guggenheim After Q3 Sales Drop
Seeking AlphaOct 31 12:19 ET

Comments

corbotron

Oct 10 09:25

I hope these bullies get decimated

$Pfizer (PFE.US)$ destroyed the shareholder confidence again. company isn't interested in shareholder value. latest threat of legal action against the former executives shows the company has no intention of curbing their careless cash spend. it's gone from creating value for shareholders to taking value from shareholders. bullies thinking they can do what they want with no repercussions. I hope their share price gets decimated over their poor decision to use forc...

Moomoo Breakfast US

Oct 10 06:53

Columns US Morning News Call | U.S. Stock Futures Drop Ahead of Key Inflation Report; Tesla Robotaxi Event Catches Attention

Expand

Tesla's "Cybercab" global debut sends stock falling

corbotron

Oct 9 15:33

$Pfizer (PFE.US)$ another positive, keep an eye $GlaxoSmithKline (GSK.US)$ $Apple (AAPL.US)$ $

Pfizer Inc - Declares $0.42 Fourth-Quarter 2024 Dividend

corbotron

Oct 9 15:07

$Pfizer (PFE.US)$ definitely an opportunity here to catch the rise, CEO will be meeting next week with new investor. discussions on directions will most likely be on the table and trimming the fat of recent acquisitions. speculation is making this stock rise until the news from the meeting is released. it's looking like there is more in the rumor mill and the price is reflecting it over the last couple sessions. keep an eye $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $GlaxoSmithKline (GSK.US)$

corbotron

Oct 9 12:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$